inverse ETFs

Investors now have more ways to invest in or against MicroStrategy Inc (NASDAQ:MSTR), a software company and Bitcoin (CRYPTO: BTC) holder that has outperformed top stocks, asset types and index funds in recent years. What Happened: REX Shares and Tuttle Capital Management launched two new ETFs...

Global equity markets have been under pressure in recent sessions amid fears of a potential U.S. recession, triggered by cooling labor market conditions and struggling manufacturing activity. Despite last month’s business surveys showing expansion in services activity, investors remain...

One well-known ETF creator filed to launch several leveraged Bitcoin ETFs – this, as cryptocurrency investors eagerly await a potential approval by the U.S. Securities and Exchange Commission (SEC) on Bitcoin ETFs. What Happened: If you haven't heard the name Matthew Tuttle, chances are you'...

How To Take Advantage Of A Recent Market Fall The stock market has been falling in recent weeks, with the S&P 500 down over 6.25% since the beginning of September. The recent market fall is due to a number of factors, including: Rising interest rates: The Federal Reserve has been raising...

A member of Congress could be raising red flags and pushing forward calls to ban trading activity by lawmakers. Here’s a look at one member of Congress betting against the market, including his past instances of taking similar positions. What Happened: Senator Thomas Carper (D-...

Electric vehicle company Tesla Inc (NASDAQ: TSLA) has been one of the top performing stocks of the last five and 10 years. As the company faces increased competition in the electric vehicle space, investors have often bet against the automaker. A handful of bearish ETFs for Tesla have popped...

MicroStrategy Incorporated (NASDAQ: MSTR) Executive Chairman Michael Saylor has been one of the most outspoken bulls for Bitcoin (CRYPTO: BTC) in recent years, a thesis that has played out at the software company he founded, which invests heavily in the leading cryptocurrency. What Happened: A new...

A leader in leveraged and inverse and thematic ETFs is launching new investment options for investors looking to place bets for or against two of the largest and most well-known companies in the world. Here are the details. What Happened: Direxion is launching the first four of its single stock...

New ETFs that offer investors the opportunity to be bullish or bearish on individual stocks hit the market this week. The new leveraged and inverse daily ETFs could be the first of many and could take on some of the largest companies in the world. What Happened: The first eight single stock...

An ETF filed Thursday would bet against one of the most loved stocks and companies and could create a battle with the world’s richest person. What Happened: Direxion filed an ETF called Direxion Daily TSLA Bear 1X Shares. The ETF would bet against Tesla Inc (NASDAQ: TSLA) on a daily basis and...

Federal Reserve meetings are one of the most consistent stock market catalysts out there. But for every bull bet on the Fed’s rate decision, there is an inverse ETF to buy to take the respective bearish stance. Here’s a look at three inverse ETFs to play the Fed. Banks and other...

In what has been a rough year for European financial services stocks and a banner year for gold miners shares, some traders might be looking to make contrarian bets. Direxion, the second-largest issuer of inverse and leveraged exchange-traded funds, is there to oblige with two new ETFs targeting...

Direxion, the second-largest issuer of inverse and leveraged exchange-traded funds, might be known for more adventurous fare such as the Direxion Daily S&P Biotech Bull 3X Shares (NYSE: LABU), Direxion Daily Gold Miners Index Bull 3X Shares (Direxion Shares Exchange Traded Fund Trust (NYSE:...

Every year when May rolls around, investors hear plenty about selling in May and going away, but what about hedging in May? After all, there are scores of inverse and leveraged exchange-traded funds risk-tolerant traders can use to capture upside, assuming markets swoon in the second half of the...

Knowing that biotechnology stocks and exchange-traded funds are struggling to start, that headline gives away the fact the ETF that is on a blistering pace is an inverse fund. With the biotech sector's well-known penchant for volatility on the way down, an ETF such as the Direxion Daily S&P...